about
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxisEmergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United StatesEvolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx proteinFailure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory studyFrequent simian foamy virus infection in persons occupationally exposed to nonhuman primatesUpdated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North AmericaAncient co-speciation of simian foamy viruses and primatesNaturally acquired simian retrovirus infections in central African huntersSimple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutationsPrevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirMinority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacyDrug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateT cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxisMeasuring enzymatic HIV-1 susceptibility to two reverse transcriptase inhibitors as a rapid and simple approach to HIV-1 drug-resistance testingHighly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in JapanLongitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage TherapyAntiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA ReservoirsGenetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkeyDual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo.Detection of murine leukemia virus or mouse DNA in commercial RT-PCR reagents and human DNAs.Clinical and virological characterization of persistent human infection with simian foamy viruses.HIV transmission in a state prison system, 1988-2005.Transmission fitness of drug-resistant HIV revealed in a surveillance system transmission networkSensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trialEmergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.No association of xenotropic murine leukemia virus-related viruses with prostate cancer.HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis.Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.Mucosal and systemic antibody responses in humans infected with simian foamy virusNo evidence of murine leukemia virus-related viruses in live attenuated human vaccines.SHIV susceptibility changes during the menstrual cycle of pigtail macaques.Investigation of hepatitis B virus and human immunodeficiency virus transmission among severely mentally ill residents at a long term care facility.A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunityDepot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipientsPrevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.
P50
Q22242951-A723AEF7-4514-4C91-80DC-9B96CEB89FFDQ24529110-E92245E8-4853-4FC6-AE9D-CF6A0C414759Q24604178-B15B2AD9-7E2C-4305-8F66-B00177C19E0DQ24605807-A585E2C3-93B7-4AD7-91FB-5DAB9541456DQ24619233-3147E9E7-C825-48B1-A5CB-81B2838B9477Q24633882-78AE038D-A28E-4E41-9D6F-FCCF297758D8Q24706655-C84D1B86-EEA9-40C5-BA66-39061EF3DFA3Q27574619-2F4A26D9-9F36-4E4C-8F19-81794353220BQ28240174-0FDC5725-EE6A-400C-B39F-AF642F1D2345Q28252669-448FC17E-E8C1-4F18-A981-F80C4B944A33Q28469253-95E6E97F-5810-412F-9E9E-FB9A9AD2629DQ28472146-D24DD73D-36CC-4FE4-8B72-028D849F666EQ28473296-B4E69F18-721C-481C-BC19-D94A17C0302BQ28474918-F648E479-515B-4F1C-8B32-38ECBE8A72A8Q28477909-B86B8617-4B40-4711-80C2-73B93A473D71Q28479215-70FC1F22-3AE6-4674-9C17-67463833F910Q28537608-5CAD1C49-2089-4818-A9C3-AA230174C305Q28547874-930BB333-42D5-4D9B-A67E-3DEDC4954B24Q28553127-C5B2F9CE-310D-4DDB-AE83-C20D07E4D066Q28750135-65F84AA8-0F31-486C-B5E2-84649052E213Q30389401-64AF02FA-C8E0-476B-A835-570DE193103AQ30424465-06038697-1B9E-40B7-A5D0-D8BB5A565AB2Q31044161-4141D168-3C35-4F8E-8BB8-BC2E9F2ED416Q33378205-D8F91A7E-0487-4D09-9235-BFC3FE173070Q33438478-D6988E51-DD3D-4073-87F6-4837BE098343Q33589187-8B0980A8-CAA2-46E3-86D4-861721EC1BD9Q33684387-BB3B7321-53D5-4FD9-A998-89F8A08A1CD2Q33820713-FBA2FDEE-2443-41B6-BB7A-BF3E682F6222Q33900919-EEE75C17-4416-4A89-8870-8F79F92F4316Q33982161-A4C8B073-5393-40DE-BA7B-3496816DFA59Q34034418-3D3FA35B-7326-4FF8-B241-00F49FCD2845Q34045576-BD60B6D1-B9EB-49D7-A234-09A49961A4C4Q34117367-3323B797-3CF3-443E-A11A-7E9E907F5EE3Q34243579-7F342CE9-D9FA-4B1E-9B8F-C4356E4DFC7DQ34399004-9C08D992-A374-48D4-A078-2F9B60E9DF72Q34399535-4FEF7B04-0595-473E-96F1-0C64340DFBBAQ34421999-96218962-691F-40AC-8F54-ED63510B5F0AQ34424673-64E8D359-F1A0-4B70-B4E8-CE8D93B47EA2Q34464721-25A19811-8683-41A2-B5DD-11009C63E786Q34506545-873743A1-3D5C-4316-AA50-3F77A39ACEBD
P50
name
Walid Heneine
@en
type
label
Walid Heneine
@en
prefLabel
Walid Heneine
@en